NanoMedicine 2024 will cover the most recent international developments in the field of Nanobiotechnology and Nanomedicine. Participants will get a complete overview on the state of the art in these fields and on the research carried out and the...
3rd BioPharma Site Solutions Summit the premier event that aims to tackle the critical challenges facing the clinical trial industry. 3rd BioPharma Site Solutions Summit the premier event that aims to tackle the critical challenges facing the...
Prostate cancer is the second-leading causes of cancer death in American men. The American Cancer Institute estimates in 2024 there will be 299,310 new cases of prostate cancer in the US and around 35,250 deaths from the disease[2]. About Clarity...
16th Asian Conference on Pharmacoepidemiology (ACPE), scheduled to take place from October 12th to 14th, 2024, in Tokyo, Japan. 16th Asian Conference on Pharmacoepidemiology (ACPE), scheduled to take place from October 12th to 14th, 2024, in...
Eisai Saudi Arabia was established in April 2024 in order to build an in-house sales system. Japan-based Eisai Co. has announced that fully-fledged operations and business activities have begun at Eisai Pharmaceuticals Single Person Limited...
in Patients with Prostate Cancer: A Comprehensive Systematic Review and Meta analysis." Journal of Nuclear Medicine (2024). About Radiohybrid Prostate‐Specific Membrane Antigen (rhPSMA): rhPSMA compounds are referred to as radiohybrid ("rh"), as...
With the global clinical trial management system market projected to rise to $2.72 billion by 2028, the pharma industry is witnessing a significant shift towards embracing technology-driven solutions to enhance efficiency, streamline processes,...
scientific challenges, enabling researchers to make meaningful advances in their fields. Promega invites attendees of SFN 2024 to Booth #1316 to experience live demonstrations of the Glomax® Galaxy, showcasing its potential to transform research....
ELRIG aims to remove as many barriers to conference attendance as possible, so all events are free to attend and with a prayer room, family room and quiet room available, ensuring our promise of inclusivity is at the heart of all our events....
The Fierce Clinical Summit 2024 is the flagship event for clinical research and trial management professionals. The Fierce Clinical Summit 2024 is the flagship event for clinical research and trial management professionals. This year’s program...
weight loss but also maintain the strength and energy they need for a healthy life." The study is set to start December 2024 at the nuHx headquarters in West Palm Beach and conclude May 2025 with published study results to follow. nuBioAge and its...
the Phase 1 trial will be presented at the Society for Immunotherapy of Cancer (SITC) Annual Meeting in early November 2024. The Phase 1 trial is conducted in collaboration with Cleveland Clinic and is funded by a grant from the U.S. Department of...
2nd Global Summit on Pharmaceutical and Medicinal Chemistry (PMC2024), which will be held in Dubai, UAE, during September 23,25, 2024. 2nd Global Summit on Pharmaceutical and Medicinal Chemistry (PMC2024), which will be held in Dubai, UAE, during...
Biotech Congress 2024 (World Biotechnology and Bioengineering Congress) is an international conference organized by the Scholars Conferences scheduled during 23-24 September 2024 at Singapore. Biotech Congress 2024 (World Biotechnology and...
4th Edition of International Conference on Tissue Engineering and Regenerative Medicine" (TERMC 2024), scheduled to take place in Rome, Italy with the added convenience of virtual attendance during September 19-21, 2024. 4th Edition of...
community to rethink how clinical research gets done to drive greater inclusivity and value for patients. DPHARM 2024 features senior clinical operation executives with industry and patient thought leadership, and technologists showcasing the...
and other bioactive substance innovations, showcased robust growth in its raw materials business in its newly released 2024 mid-year financial report. The company reported a total revenue of RMB 2.811 billion (～ USD 393.54 million) for the first...
will hold an advisory committee meeting with the Cardiovascular and Renal Drugs Advisory Committee (CRDAC) on October 10, 2024 to evaluate the New Drug Application (NDA) for elamipretide, the first potential therapy for Barth syndrome. This...
The 3rd Biologics Contract Manufacturing Asia 2024 is a premium event that focuses exclusively on Contract Manufacturing in Asia-Pacific. The 3rd Biologics Contract Manufacturing Asia 2024 is a premium event that focuses exclusively on Contract...
of Clinical Oncology and the Lancet Digital Health, and presented at global conferences such as the ASCO and RSNA. In 2024, Lunit acquired Volpara Health Technologies, setting the stage for unparalleled synergy and accuracy, particularly in breast...
